Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Anderson, D., Tucker, L., and Gallion, T., 1992, Optimization of culture conditions for detection of infectious HIV-1 in semen, Int. Conf. AIDS 8:19–24.
Bagasra, O., Farzadegan, H., Seshamma, T., Oakes, J. W., Saah, A., and Pomerantz, R. J., 1994, Detection of HIV-1 proviral DNA in sperm from HIV-1 infected men, AIDS 8:1669–1674.
Milman, G., and Sharma, O., 1994, Mechanisms of HIV/SIV mucosal transmission, AIDS Res.Hum.Retrovir. 10:1305–1312.
Hussain, L. A., and Lehner, T., 1995, Comparative investigation of Langerhans’ cells and potential receptors for HIV in oral, genitourinary and rectal epithelia, Immunology 85: 475–484.
Soto-Ramirez, L. E., Renjifo, B., McLane, M. F., Marlink, R., O’Hara, C., Sutthent, R., Wasi, C., Vithayasai, P., Vithayasai, V., Apichartpiyakul, C., Auewarakul, P., Cruz, V. P., Chui, D.-S., Osathanondh, R., Mayer, K, Lee, T.-H., and Essex, M., 1996, HIV-1 Langerhans’ cell tropism associated with heterosexual transmission of HIV, Science 271:1291–1292.
Egeler, R. M., 1993, Langerhans cell histiocytosis and other histiocytic disorders, Thesis, University of Amsterdam, Amsterdam, Netherlands.
Lombardi, T., Hauser, C., and Budtz-Jorgensen, E., 1993, Langerhans cells: Structure, function and role in oral pathological conditions, J. Oral Pathol. Med. 22193–202.
Toews, G. B., Bergstresser, P. R., and Streilein, J. W., 1980, Epidermal Langerhans cell density determines whether contact hypersensitivity or unresponsiveness follows skin painting with DNFB, J. Immunol. 124445–451.
Schmitt, D., and Dezutter-Dambuyant, C., 1994, Epidermal and mucosal dendritic cells and HIV1 infection, Path. Res. Pract. 190:955–959.
Van Wilsem, E. J., Van Hoogstraten, I. M., Breve, J., Scheper, R. J., and Kraal, G., 1994, Dendritic cells of the oral mucosa and the induction of oral tolerance. A local affair, Immunology83:128–132.
Cella, M., Scheidegger, D., Palmer-Lehmann, K, and Lane, P., 1996, Ligation of CD40 on dendritic cells triggers production of high levels of interleukin-12 and enhances T cell stimulatory capacity: T-Thelp via APC activation, J. Exp. Med. 184:747–752.
Pimentel-Muinos, F. X., Lopez-Geurrero, J. A., Fresno, M., and Alonso, M. A., 1992, CD4 gene transcription is transiently repressed during differentiation of myeloid cells to macrophage-like cells, Eur J. Biochem. 207:321–325.
Maddon, P. J., Dalgleish, A. G., McDougal, J. S., Clapham, P. R., Weiss, R. A., and Axel, R., 1986, The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain, Cell 47:333–348.
Arthur, L. O., Bess, Jr., J. W., Sowder 11, R. C., Benveniste, R. E., Mann, D. L., Chermann, J.-C., and Henderson, L. E., 1992, Cellular proteins bound to immunodeficiency viruses: Implications for pathogenesis and vaccines, Science 258:1935–1938.
McKeating, J. A., Griffiths, P. D., and Weiss, R. A., 1990, HIV susceptibility conferred to human fibroblasts by cytomegalovirus-induced Fc receptor, Nature 343:659–661.
Delibrias, C. C., Kazatchkine, M. D., and Fischer, E., 1993, Evidence for the role of CRl (CD35), in addition to CR2 (CD21), in facilitating infection of human T cells with opsonized HIV. Scand J. Immunol. 38:183–189.
Dezutter-Dambuyant, C., Schmitt, D. A., Dusserre, N., Hanau, D., Kolbe, H. V. J., Kieny, M. P., Gazzolo, L., Mace, K., Pasquali, J.-L., Olivier, R., and Schmitt, D., 1991, Trypsinresistant gp120 receptors are upregulated on short-term cultured human epidermal Langerhans cells, Res. Virol. 142:129–138.
Wolff, H., Martinez, A., Politch, J., Saltzman, S., Mayer, K., and Anderson, D. J., 1989, Detection and quantification of HIV-1 antibodies in semen, Int. Conf. AIDS 5:181.
Belec, L., Tevi-Benissan, C., Lu, X. S., Prazuck, T., and Pillot, J., 1995, Local synthesis of IgG antibodies to HIV within the female and male genital tracts during asymptomatic and pre-AIDS stages of HIV infection, AIDS Res. Hum. Retroviruses 11:719–729.
Kotler, D. P., Scholes, J. V., and Tierney, A. R., 1987, Intestinal plasma cell alternations in acquired immunodeficiency syndrome, Dig. Dis. Sci. 32:129–138.
Fadian, N. S., Shiboski, S. C., and Jewell, N. P., 1990, The effect of number of exposures on the risk of heterosexual HIV transmission, J. Infect. Dis. 161:883–887.
Levin, L. I., Peterman, T. A., Renzullo, P. O., Lasley-Bibbs, V., Shu, X. O., Brundage, J. F., and McNeil, J. G., 1995, HIV-1 seroconversion and risk behaviors among young men in the US army. The Seroconversion Risk Factor Study Group, Am. J. Public Health 85:1500–1506.
Miller, C. J., 1994, Animal models of viral sexually transmitted disease, Am. J. Reprod. Immunol. 31:52–63.
Wolff, H., 1995, The biologic significance of white blood cells in semen, Fertil. Steril. 63:1143–1157.
Hattori, T., Koito, A., Takatsuki, K., Kido, H., and Katunuma, N., 1989, Involvement of tryptase-related cellular protease (s) in human immunodeficiency virus type, FEBS Lett. 248:48–52.
Clements, G. J., Price-Jones, M. J., Stephens, P. E., Sutton, C., Schulz, T. F., Clapham, P. R., McKeating, J. A., McClure, M. O., Thomson, S., Marsh, M., Kay, J., Weiss, R. A., and Moore, J. P., 1991, The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage, AIDS Res. Hum. Retroviruses 7:3–16.
Harvima, I. T., Harvima, R. J., Nilsson, G., Ivanoff, L., and Schwartz, L. B., 1993, Separation and partial characterization of proteinases with substrate specificity for basic amino acids from human MOLT4 T lymphocytes: Identification of those inhibited by variable-loop V3 peptides of HIV-1 (human immunodeficiency virus-1) envelope glycoprotein, Biochem. J. 292:711–718.
Avril, L.-E., di Martino-Ferrer, M., Pignede, G., Seman, M., and Gauthier, F., 1994, Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G, FEBS Lett. 345:81–86.
Bristow, C. L., Fiscus, S. A., Flood, P. M., and Arnold, R. R., 1995, Inhibition of HIV-1 by modification of a host membrane protease, Int. Immunol. 7:239–249.
Isaacs, W. B., and Coffey, D. S., 1984, The predominant protein of canine seminal plasma is an enzyme, J Biol. Chem. 259:11520–11526.
Skibinski, G., Kelly, R. W., Harkiss, D., and James, K., 1992, Immunosuppression by human seminal plasma-extracellular organelles (prostasomes) modulate activity of phagocytic cells, Am. J. Reprod. Immunol. 28:97–103.
Husby, S., Mestecky, J., Moldoveanu, Z., Holland, S., and Elson, C. O., 1994, Oral tolerance in humans, J. Immunol. 152:4663–4670.
Crago, S. S., and Mestecky, J., 1983, Immunoinhibitory elements in human colostrum, Surv. Immunol. Res. 2:164–169.
Streilein, J. W., Stein-Streilein, J., and Head, J., 1986, Regional specialization in antigen presentation, in: The Reticuloendothelial System (S. M. Phillips and M. R. Escobar, eds.), Plenum Press, New York, pp. 37–93.
Moldoveanu, Z., Russell, M. W., Wu, H. Y., Huang, W.-Q., Compans, R. W., and Mestecky, J., 1995, Compartmentalization within the common mucosal immune system, in: Advances in MucosalImmunology (J. Mestecky, ed.), Plenum Press, New York, pp. 97–101.
Lifson, J. D., Nowak, M. A., Goldstein, S., Rossio, J. L., Kinter, A., Vasquez, G., Wiltrout, T. A., Brown, C., Schneider, D., Wahl, L., Lloyd, A. L., Williams, J., Elkins, W. R., Fauci, A. S., and Hirsch, V. M., 1997, The extent of early viral replication is a critical determinant of the natural history of simian immunodeficiency virus infection, J. Virol. 71:9508–9514.
Meltzer, M. S., Skillman, D. R., Gomatos, P. J., Kalter, D. C., and Gendelman, H. E., 1990, Role of mononuclear phagocytes in the pathogenesis of human immunodeficiency virus infection, Annu. Rev. Immunol. 8:169–194.
McDermott, M. R., Befus, A. D., and Bienenstock, J., 1983, The structural basis of immunity in the respiratory tract, in: International Review of Experimental Pathology (G. W. Richter and M. A. Epstein, eds.), Academic Press, New York, pp. 47–112.
Gendelman, H. E., Orenstein, J. M., Martin, M. A., Ferrua, C., Mitra, R. T., Phipps, T., Wahl, L. A., Lane, H. C., Fauci, A. S., Burke, D. S., Skillman, D., and Meltzer, M. S., 1988, Efficient isolation and propagation of human immunodeficiency virus on recombinant colony stimulating factor 1-treated monocytes, J. Exp. Med. 167:1428–1434.
Orenstein, J. M., Meltzer, M. S., Phipps, T., and Gendelman, H. E., 1988, Cytoplasmic assembly and accumulation of human immunodeficiency virus types 1 and 2 in recombinant human colony stimulating factor-1 treated human monocytes: An ultrastructural study, J. Virol. 62:2578–2585.
Meltzer, M. S., Hoover, D. L., Finbloom, D. S., Turpin, J. A., Kalter, C., Friedman, R. M., Moyer, M. P., Nara, P., and Gendelman, H. E., 1993, Mononuclear phagocytes in the pathogenesis of human immunodeficiency virus disease, in: MononuclearPhagocytes in Cell Biology (G. Lopez-Berestein and J. Klostergaard, eds.), CRC Press, Boca Raton, Florida, pp. 147–175.
Adams, D. O., and Johnson, S. P., 1992, Molecular bases of macrophage activation: Regulation of class II MHC genes in tissue macrophages, in: MononuclearPhagocytes. Biology of Monocytes and Macrophages (R. vanFurth, ed.), Kluwer, Dordrecht, The Netherlands, pp. 425–436.
Winslow, B. J., Pomerantz, R. J., Bagasra, O., and Trono, D., 1993, HIV-1 latency due to the site of proviral integration, Virology 196:849–854.
Chun, T. W., Finzi, D., Margolick, J., Chadwick, K., Schwartz, D., and Siliciano, R. F., 1996, In vivofate of HIV-1-infected T cells: Quantitative analysis of the transition to stable latency, NatureMed. 1:1284–1290.
Montefiori, D. C., Cornell, R. J., Zhou, J. Y., Zhou, J. T., Hirsch, V. M., and Johnson, P. R., 1994, Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection, Virology 205:82–92.
Tremblay, M., Meloche, S., Sekaly, R.-P., and Wainberg, M. A., 1990, Complement receptor 2 mediates enhancement of human immunodeficiency virus 1 infection in Epstein-Barr virus-carrying B cells, J. Exp. Med. 171:1791–1796.
Rizzuto, C. D., and Sodroski, J. G., 1997, Contribution ofvirion ICAM-I to human immuno-deficiency virus infectivity and sensitivity to neutralization, J. Virol. 71:4847–4851.
Brighty, D. W., Rosenberg, M., Chen, I. S. Y., and Ivey-Hoyle, M., 1991, Envelope proteins from clinical isolates of human immunodeficiency virus type 1 that are refractory to neutralization by soluble CD4 possess high affinity for the CD4 receptor, Proc. Natl. Acad. Sci. USA 88:7802–7805.
Horak, I. D., Popovic, M., Horak, E. M., Lucas, P. J., Gress, R. E., June, C. H., and Bolen, J. B., 1990, No T-cell protein kinase signalling or calcium mobilization after CD4 association with HIV-1 or HIV-1 gp120, Nature 348:557–560.
Cefai, D., Debre, P., Kaczorek, M., Idziorek, T., Autran, B., and Bismuth, G., 1990, Human immunodeficiency virus-1 glycoproteins gp120 and gp160 specifically inhibit the CD3/T cell-antigen receptor phosphoinositide transduction pathway, J. Clin. Invest. 86:2117–2124.
Collman, R., Godfrey, B., Cutilli, J., Rhodes, A., Hassan, N. F., Sweet, R., Douglas, S. D., Friedman, H., Nathanson, N., and Gonzalez-Scarano, F., 1990, Macrophage-tropic strains of human immunodeficiency virus type 1 utilize the CD4 receptor, J. Virol. 64:4468–4476.
Stamatatos, L., Werner, A., and Cheng-Meyer, C., 1994, Differential regulation of cellular tropism and sensitivity to soluble CD4 neutralization by the envelope gp120 of human immunodeficiency virus type 1, J. Virol 68:4973–4979.
Sonza, S., Maerz, A., Uren, S., Violo, A., Hunter, S., Boyle, W., and Crowe, S., 1995, Susceptibility of human monocytes to HIV type 1 infection in vitro is not dependent on their level of CD4 expression, AIDS Res. Hum. Retroviruses 11:769–776.
de Maria, A., Pantaleo, G., Schnittman, S. M., Greenhouse, J. J., Baseler, M., Orenstein, J. M., and Fauci, A. S., 1991, Infection of CD8+ T lymphocytes with HIV: Requirement for interaction with infected CD4+ cells and induction of infectious virus from chronically infected CD8+ cells, J. Immunol. 146:2220–2226.
Lusso, P., Lori, F., and Gallo, R. C., 1990, CD4-independent infection by human immuno-deficiency virus type 1 after phenotypic mixing with human Tcell leukemia viruses, J. Virol. 64:6341–6344.
Feng, Y., Broder, C. C., Kennedy, P. E., and Berger, E. A., 1996, HIV-1 entry cofactor: Functional cDNA cloning of a seven-transmembrane, G protein-coupled receptor, Science 272: 872–877.
Cocchi, F., De Vico, A. L., Garzino-Demo, A., Arya, S. R, Gallo, R. C., and Lusso, P., 1995, Identification of RANTES, MIP-1α, and MIP-1β as the major HIV suppressive factors produced by CD8+ T cells, Science 270:1811–1815.
Bristow, C. L., 1996, HIV fusion, Science 273:1642–1643.
Mackewicz, C. E., Barker, E., and Levy, J. A., 1996, Role of β-chemokines in suppressing HIV replication, Science 274:1393–1394.
Moriuchi, H., Moriuchi, M., and Fauci, A. S., 1997, Nuclear factor-kB potently upregulates the promoter activity of RANTES, a chemokine that blocks HIV infection, J. Immunol.
Shaw, G. M., Harper, M. E., Hahn, B. H., Epstein, L. G., Gajdusek, D. C., Price, R. W., Navia, B. A., Petito, C. R, O’Hara, C. J., Groopman, J. E., et al., 1985, HTLV-III infection in brains of children and adults with AIDS encephalopathy, Science 227:177–182.
Cohen, 0. J., Pantaleo, G., Walker, R., Ognibene, F. P., Shelhamer, J. H., and Fauci, A. S., 1993, Comparative analysis of HIV burden in mononuclear cells (MC) from peripheral blood (PB) versus bronchoalveolar lavage (BAL) of the same individuals, Int. Conf. AIDS 9:62.
Lebargy, F., Branellec, A., Deforges, L., Bignon, J., and Bernaudin, J. F., 1994, HIV-1 in human alveolar macrophages from infected patients is latent in vivo but replicates after in vitro stimulation, Am.J. Respir. CellMol. Biol. 10:72–78.
Stanley, S. R, Kessler, S. W., Justement, J. S., Schnittman, S. M., Greenshouse, J. J., Brown, C. C., Musongela, L., Musey, R, Kapita, B., and Fauci, A. S., 1992, CD34+ bone marrow cells are infected with HIV in a subset of seropositive individuals, J. Immunol. 149:689–697.
Rappersberger, K., Gartner, S., Schenk, P., Stingl, G., Groh, V., Tschachler, E., Mann, D. L., Wolff, R, Konrad, R, and Popovic, M., 1988, Langerhans’ cells are an actual site of HIV-1 replication, Intervirology 29:185–194.
Fauci, A. S., 1993, Multifactorial nature of human immunodeficiency virus disease: Implications for therapy, Science262:1011–1018.
Reimann, K. A., Tenner-Racz, K, Racz, P., Montefiori, D. C., Yasutomi, Y., Lin, W., Ransil, B. J,, and Letvin, N. L., 1994, Immunopathogenic events in acute infection of rhesus monkeys with simian immunodeficiency virus of macaques, J. Virol. 68:2362–2370.
Chakrabarti, L., Isola, P., Cumont, M.-C., Claessens-Maire, M. A., Hurtrel, M., Montagnier, L., and Hurtrel, B., 1994, Early stages of simian immunodeficiency virus infection in lymph nodes. Evidence for high viral load and successive populations of target cells, Am.J. Pathol. 144:1226–1237.
Joling, P., Bakker, L. J., Van Strijp, J. A. G., Meerloo, T., de Graaf, L., Dekker, M. E., Goudsmit, J., Verhoef, J., and Schuurman, H.-J., 1993, Binding of human immunodeficiency virus type-1 to follicular dendritic cells in vitro is complement dependent, J. Immunol. 150:1065–1073.
Klaus, G. G. B., and Humphrey, J. H., 1993, The fate of antigens, in: Clinical Aspects of Immunology, 5th ed. (P. J. Lachmann, K. Peters, F. S. Rosen, and M. J. Walport, eds.), Blackwell, Boston, pp. 107–126.
Hussey, R. E., Richardson, N. E., Kowalski, M., Brown, N. R., Chang, H.-C., Siliciano, R. F., Dorfman, T., Walker, B., Sodroski, J., and Reinherz, E. L., 1988, A soluble CD4 protein selectively inhibits HIV replication and syncytium formation, Nature 331:78–81.
Deen, K. C., McDougal, S., hacker, R., Folena-Wasserman, G., Arthos, J., Rosenberg, J., Maddon, P. J., Axel, R., and Sweet, R. W., 1988, A soluble form of CD4 (T4) protein inhibits AIDS virus infection, Nature 331:82–84.
Fisher, R A., Bertonis, J. M., Werner, M., Johnson, V. A., Costopoulos, D. S., Liu, T., and Tizard, R., 1988, HIV infection is blocked in vitro by recombinant soluble CD4, Nature 331:76–78.
Cummins, L. M., Weinhold, K. J., Matthews, T. J., Langlois, A. J., Perno, C. F., Condie, R. M., and Allah, J.-P., 1991, Preparation and characterization of an intravenous solution of IgG from human immunodeficiency virus-seropositive donor, Blood 77:1111–1117.
Harakeh, S., Jariwalla, R. J., and Paulling, L., 1990, Suppression of human immunodeficiency virus replication by ascorbate in chronically and acutely infected cells, Proc. Natl. Acad. Sci. USA 87:7245–7249.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2002 Kluwer Academic Publishers
About this chapter
Cite this chapter
Bristow, C.L. (2002). The Two Principal Viremias of HIV. In: Ugen, K.E., Bendinelli, M., Friedman, H. (eds) Human Retroviral Infections. Infectious Agents and Pathogenesis. Springer, Boston, MA. https://doi.org/10.1007/0-306-46819-0_1
Download citation
DOI: https://doi.org/10.1007/0-306-46819-0_1
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-306-46222-1
Online ISBN: 978-0-306-46819-3
eBook Packages: Springer Book Archive